Johnson & Johnson starts human study of COVID-19 vaccine after promising monkey data

Johnson & Johnson on Thursday kicked off U.S. human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys that showed its best-performing vaccine candidate offered strong protection in a single dose. Read Article